Loading...
Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift
Palliation of symptoms related to malignancy-associated hypercalcemia (MAH) is essential and clinically meaningful for patients, given the continued poor prognosis, with high morbidity and mortality associated with this disease process. Historically, agents have been temporizing, having no impact on...
Na minha lista:
| Udgivet i: | Endocr Connect |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Bioscientifica Ltd
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7923058/ https://ncbi.nlm.nih.gov/pubmed/33289687 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-20-0487 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|